<DOC>
	<DOCNO>NCT02219633</DOCNO>
	<brief_summary>The aim trial ass efficacy LEO 39652 cream compare LEO 39652 cream vehicle adult mild moderate AD 3 week treatment .</brief_summary>
	<brief_title>Effect LEO 39652 Cream Adults With Mild Moderate Atopic Dermatitis ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Subjects Atopic Dermatitis ( AD ) define Hanifin Rajka criterion mild moderate disease severity ( IGA 2 3 ) Two symmetrical comparable Entire Treatment Areas , body region ( leave right part ) Subjects must good health Female subject childbearing potential male subject must willing consent use high effective method contraception Any condition treatment area opinion investigator could interfere clinical assessment , e.g . acne , infection , rash ( atopic dermatitis ) , sunburn , hyperor hypopigmentation , scar Darkskinned person ( i.e . skin type IV VI accord Fitzpatrick classification system ) whose skin colour prevents reliable clinical assessment Any permanent ( transient within 28 day prior dose ) disease ( particular cardiac disease heart failure history myocardial infarction ) may interfere subject safe participation trial , subject ability participate trial clinical assessment Subjects congenital acquire immunodeficiency subject therapy cause immunosuppression</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>